e-learning
resources
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
Mandy Menzel, Hamid Akbarshahi, Irma Mahmutovic Persson, Manoj Puthia, Leif Bjermer, Lena Uller
Source:
ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mandy Menzel, Hamid Akbarshahi, Irma Mahmutovic Persson, Manoj Puthia, Leif Bjermer, Lena Uller. Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model. ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Decreased peribronchial fibrosis in chronic ovalbumin-induced asthma model of PI3K deficiency mice
Source: Eur Respir J 2005; 26: Suppl. 49, 26s
Year: 2005
IL-33 in patients with severe uncontrolled allergic asthma
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Levofloxacin prevents eosinophil activation and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 207s
Year: 2006
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Source: ERS Lung Science Conference 2019
Year: 2019
Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002
HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept